Biomarkers in reproductive medicine: the promise, and can it be fulfilled?

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Fertility and Sterility

• Publication date

  2013-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.fertnstert.2012.11.019PMID 23246448PMCID PMC3602311
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Working paper 7

  2014cited by this paper
• Genome-Wide Analysis of Human Preimplantation Aneuploidy

  2012cited by this paper
• Non-invasive metabolomic profiling of Day 2 and 5 embryo culture medium: a prospective randomized trial.

  2012cited by this paper
• Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.

  2012cited by this paper
• Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration

  2012cited by this paper
• Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis.

  2012cited by this paper
• Disability outcomes and dose escalation with etanercept, adalimumab, and infliximab in rheumatoid arthritis patients: a US-based retrospective comparative effectiveness study

  2012cited by this paper
• An In Vitro Diagnostic Multivariate Index Assay (IVDMIA) for Ovarian Cancer: Harvesting the Power of Multiple Biomarkers.

  2012cited by this paper
• Assessment of leukemia inhibitory factor and glycoprotein 130 expression in endometrium and uterine flushing: a possible diagnostic tool for impaired fertility

  2012cited by this paper
• Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration

  2012cited by this paper
• Pathogenesis and pathophysiology of endometriosis.

  2012influential reference
• Personalized Medicine: Trends and Prospects for the New Science of Genetic Testing and Molecular Diagnostics-Working Paper 7

  2012cited by this paper
• Diagnosis of Endometriosis: Biomarkers

  2012cited by this paper
• Regulation of female reproduction by p53 and its family members

  2011cited by this paper
• Endometriosis Science and Practice

  2011cited by this paper
• Incidence of endometriosis by study population and diagnostic method: the ENDO study.

  2011cited by this paper
• Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study.

  2011cited by this paper
• Association of cyclophosphamide drug-metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors.

  2010cited by this paper
• Effect of hormone metabolism genotypes on steroid hormone levels and menopausal symptoms in a prospective population-based cohort of women experiencing the menopausal transition

  2010cited by this paper
• Assessing the Clinical Utility of Diagnostics Used in Drug Therapy

  2010cited by this paper
• Human Endometrial CD98 Is Essential for Blastocyst Adhesion

  2010cited by this paper
• Peripheral biomarkers of endometriosis: a systematic review.

  2010cited by this paper
• Does a prediction model for pregnancy of unknown location developed in the UK validate on a US population?

  2010cited by this paper
• Endometrial claudin-4 and leukemia inhibitory factor are associated with assisted reproduction outcome

  2009influential reference
• Clinical utility of progesterone receptor modulators and their effect on the endometrium

  2009cited by this paper
• The p53 codon 72 single nucleotide polymorphism lacks a significant effect on implantation rate in fresh in vitro fertilization cycles: an analysis of 1,056 patients.

  2009cited by this paper
• Single-nucleotide polymorphisms in the p53 pathway regulate fertility in humans

  2009cited by this paper
• Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator

  2009cited by this paper
• Recombinant human leukemia inhibitory factor does not improve implantation and pregnancy outcomes after assisted reproductive techniques in women with recurrent unexplained implantation failure.

  2009cited by this paper
• Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study.

  2009cited by this paper
• The p53 codon 72 single nucleotide polymorphism lacks a significant effect on implantation and outcome rates in fresh IVF cycles: an analysis of 1056 patients

  2008cited by this paper
• Controlled ovarian stimulation induces a functional genomic delay of the endometrium with potential clinical implications.

  2008cited by this paper
• An exploration into study design for biomarker identification: issues and recommendations.

  2007cited by this paper
• The accelerated pace of pharma abandonment of research and development in family planning and fertility: will reproductive health technology be frozen in time?

  2007cited by this paper
• The Statistical Evaluation of Medical Tests for Classification and Prediction

  2005cited by this paper
• The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration

  2003cited by this paper
• The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration.

  2003cited by this paper
• Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled Trial

  2003cited by this paper
• Molecular diagnosis of ectopic pregnancy

  2002cited by this paper
• Validation of biomarkers as early predictors of disease.

  2001cited by this paper
• Phases of biomarker development for early detection of cancer.

  2001cited by this paper
• We are overinterpreting the predictive value of serum follicle-stimulating hormone levels.

  1999cited by this paper
• The use of biological markers as predictive early-outcome measures in epidemiological research.

  1997cited by this paper
• Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories.

  1995cited by this paper

• Evaluation of serum calponin‐2 in the differential diagnosis of pregnancy of unknown location: A prospective analysis

  2025cites this paper
• IL‐17 Producing T to Foxp3+CD4+ Regulatory T Cell Ratio as a Diagnostic and Prognostic Marker in Women With Recurrent Pregnancy Loss and Its Implications for Intravenous Immunoglobulin Therapy

  2024cites this paper
• Multiplexed Serum Biomarkers to Discriminate Nonviable and Ectopic Pregnancy.

  2024cites this paper
• Immune system cells modulation in patients with reproductive issues: A systematic review approach

  2023cites this paper
• Evaluation of novel biomarkers for early pregnancy outcome prediction

  2023cites this paper
• Validation of a multiple marker test for early pregnancy outcome prediction

  2023cites this paper
• Application of a Multiplex Platform to Identify Novel Biomarkers for Pregnancy Location and Viability

  2023cites this paper
• Application of a Multiplex Platform to Identify Novel Biomarkers for Pregnancy Location and Viability

  2023cites this paper
• Demetra Application: An integrated genotype analysis web server for clinical genomics in endometriosis

  2021cites this paper
• Nanotechnology in reproductive medicine: Opportunities for clinical translation

  2020cites this paper
• Endometriosis research in the -omics era (Review).

  2020cites this paper
• Predicting Embryo Developmental Potential and Viability Using Automated Time-Lapse Analysis (Eeva™ Test)

  2019cites this paper
• Technical Verification and Assessment of Independent Validation of Biomarker Models for Endometriosis

  2019cites this paper
• Endometriosis biomarkers: Will codevelopment in academia–industry partnerships result in new and robust noninvasive diagnostic tests?

  2019cites this paper
• Evaluation, validation and refinement of noninvasive diagnostic biomarkers for endometriosis (ENDOmarker): A protocol to phenotype bio-specimens for discovery and validation.

  2018cites this paper
• Chronic Stress and Reproductive Function in Female Childhood Cancer Survivors

  2018cites this paper
• Developing a deeper insight into reproductive biomarkers

  2017cites this paper
• Peripheral Blood Biomarkers for Endometriosis

  2017cites this paper
• OMICs Studies and Endometriosis Biomarker Identification

  2017cites this paper
• Interleukin‐6, intracellular adhesion molecule‐1, and glycodelin A levels in serum and peritoneal fluid as biomarkers for endometriosis

  2016cites this paper
• Serum concentrations of the biomarkers CA125, CA15-3, PSA and PAPP-A in early pregnancy

  2016cites this paper
• Novel diagnostic tests of ectopic pregnancy, if at first you don't succeed...

  2015cites this paper
• Specific gene expression differences in cumulus cells as potential biomarkers of pregnancy.

  2015cites this paper
• Bringing epigenetics into the diagnostics of the andrology laboratory: challenges and perspectives

  2014cites this paper
• Molecular Network Analysis of Endometriosis Reveals a Role for c-Jun–Regulated Macrophage Activation

  2014cites this paper
• Endocannabinoids as biomarkers of human reproduction.

  2014influential citation
• Using the Eeva Test™ adjunctively to traditional day 3 morphology is informative for consistent embryo assessment within a panel of embryologists with diverse experience

  2014cites this paper
• Can chemokines be used as biomarkers for endometriosis? A systematic review.

  2014cites this paper
• Biomarkers of disease : concentrations in the serum of women during natural and stimulated ovarian cycles and during early pregnancy

  2013influential citation
• Biomarkers identified with time-lapse imaging: discovery, validation, and practical application.

  2013cites this paper
• The assisted reproductive technology laboratory: toward evidence-based practice?

  2013cites this paper
• MIT Open Access

  year unknowncites this paper